These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10758302)

  • 21. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.
    Benasso M; Corvò R; Numico G; Cavallari M; Blengio F; Sanguineti G; Rosso M; Merlano M
    Anticancer Res; 1995; 15(6B):2651-4. PubMed ID: 8669841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
    De Sanctis V; Bossi P; Sanguineti G; Trippa F; Ferrari D; Bacigalupo A; Ripamonti CI; Buglione M; Pergolizzi S; Langendjik JA; Murphy B; Raber-Durlacher J; Russi EG; Lalla RV
    Crit Rev Oncol Hematol; 2016 Apr; 100():147-66. PubMed ID: 26947812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent cisplatin, infusional fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer: dose-limiting mucosal toxicity.
    Denham JW; Abbott RL
    J Clin Oncol; 1991 Mar; 9(3):458-63. PubMed ID: 1999716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model.
    Strigari L; Pinnarò P; Carlini P; Torino F; Strolin S; Minosse S; Sanguineti G; Benassi M
    Crit Rev Oncol Hematol; 2016 Jun; 102():101-10. PubMed ID: 27157527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered fractionation: limited by mucosal reactions?
    Kaanders JH; van der Kogel AJ; Ang KK
    Radiother Oncol; 1999 Mar; 50(3):247-60. PubMed ID: 10392810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head and neck squamous cell carcinoma: optimizing the therapeutic index.
    Rosenthal DI; Blanco AI
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
    Mantovani G; Proto E; Massa E; Mulas C; Madeddu C; Mura L; Mudu MC; Astara G; Murgia V; Gramignano G; Ferreli L; Camboni P; Lusso MR; Mocci M; Tore G; Mura M; Amichetti M; Maccio A
    Int J Oncol; 2002 Feb; 20(2):419-27. PubMed ID: 11788911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study.
    Schaefer U; Micke O; Schueller P; Willich N
    Radiology; 2000 Aug; 216(2):371-6. PubMed ID: 10924555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer.
    Watkins JM; Zauls AJ; Wahlquist AH; Shirai K; Garrett-Mayer E; Gillespie MB; Day TA; Sharma AK
    Laryngoscope; 2010 Feb; 120(2):236-42. PubMed ID: 19950378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
    Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
    Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor.
    Peters LJ; Withers HR
    Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):831-6. PubMed ID: 9369130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined-modality therapy for head and neck cancer.
    Fu KK
    Oncology (Williston Park); 1997 Dec; 11(12):1781-90, 1796; discussion 1796, 179. PubMed ID: 9436185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy.
    Rosso M; Blasi G; Gherlone E; Rosso R
    J Chemother; 1997 Oct; 9(5):382-5. PubMed ID: 9373795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in understanding of toxicities of treatment for head and neck cancer.
    Logan RM
    Oral Oncol; 2009 Oct; 45(10):844-8. PubMed ID: 19467918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiosensitizing with cis-platin in advanced head and neck cancer. Results and problems.
    Klima A; Desloovere C; Lörz M
    Acta Otorhinolaryngol Belg; 1989; 43(3):231-8. PubMed ID: 2694749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined modalities in the treatment of head and neck cancers.
    Aisner J; Hiponia D; Conley B; Jacobs M; Gray W; Belani CP
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):28-34. PubMed ID: 7541154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant chemoradiotherapy for advanced head and neck cancer.
    Lin JC; Jan JS; Hsu CY
    Jpn J Clin Oncol; 1994 Apr; 24(2):94-100. PubMed ID: 8158863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
    Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
    Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.